Cargando…

Therapeutic Potential of the Molecular Chaperone and Matrix Metalloproteinase Inhibitor Clusterin for Dry Eye

Evidence is presented herein supporting the potential of the natural homeostatic glycoprotein CLU (clusterin) as a novel therapeutic for the treatment of dry eye. This idea began with the demonstration that matrix metalloproteinase MMP9 is required for damage to the ocular surface in mouse dry eye....

Descripción completa

Detalles Bibliográficos
Autores principales:	Fini, M. Elizabeth, Jeong, Shinwu, Wilson, Mark R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7794831/ https://www.ncbi.nlm.nih.gov/pubmed/33374364 http://dx.doi.org/10.3390/ijms22010116

Ejemplares similares

Clusterin Seals the Ocular Surface Barrier in Mouse Dry Eye
por: Bauskar, Aditi, et al.
Publicado: (2015)

Expression and Purification of Chaperone-Active Recombinant Clusterin
por: Dabbs, Rebecca A., et al.
Publicado: (2014)

Matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of metalloproteinases 1 (TIMP-1) are localized in the nucleus of retinal Müller glial cells and modulated by cytokines and oxidative stress
por: Lee, Eun-Jin, et al.
Publicado: (2021)

Recombinant Human Clusterin Seals Damage to the Ocular Surface Barrier in a Mouse Model of Ophthalmic Preservative-Induced Epitheliopathy
por: Chintala, Shravan K., et al.
Publicado: (2023)

Clusterin Silencing in Prostate Cancer Induces Matrix Metalloproteinases by an NF-κB-Dependent Mechanism
por: Bonacini, Martina, et al.
Publicado: (2019)

The Extracellular Molecular Chaperone Clusterin Inhibits Amyloid Fibril Formation and Suppresses Cytotoxicity Associated with Semen-Derived Enhancer of Virus Infection (SEVI)
por: Elias, Abigail K., et al.
Publicado: (2022)

The extracellular chaperone Clusterin enhances Tau aggregate seeding in a cellular model
por: Yuste-Checa, Patricia, et al.
Publicado: (2021)

Matrix Metalloproteinases in Chemoresistance: Regulatory Roles, Molecular Interactions, and Potential Inhibitors
por: Tune, Bernadette Xin Jie, et al.
Publicado: (2022)

Matrix metalloproteinases as therapeutic targets in breast cancer
por: Kwon, Mi Jeong
Publicado: (2023)

Expression of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases in the hair cycle
por: HOU, CHUN, et al.
Publicado: (2016)

High Levels of 17β-Estradiol Are Associated with Increased Matrix Metalloproteinase-2 and Metalloproteinase-9 Activity in Tears of Postmenopausal Women with Dry Eye
por: Shen, Guanglin, et al.
Publicado: (2016)

Antisense Oligonucleotide Against Clusterin Regulates Human Hepatocellular Carcinoma Invasion Through Transcriptional Regulation of Matrix Metalloproteinase-2 and E-Cadherin
por: Chen, Dong, et al.
Publicado: (2012)

Molecular Imaging Probes Based on Matrix Metalloproteinase Inhibitors (MMPIs)
por: Rangasamy, Loganathan, et al.
Publicado: (2019)

Functionalized Hyaluronic Acid for “In Situ” Matrix Metalloproteinase Inhibition: A Bioactive Material to Treat the Dry Eye Sydrome
por: Burgalassi, Susi, et al.
Publicado: (2022)

Comparative Evaluation of Matrix Metalloproteinase-9 Immunoassay and Tear Osmolarity Measurement for Diagnosing Severity of Dry Eye Disease
por: Choi, Moonjung, et al.
Publicado: (2023)

Clusterin is a potential molecular predictor for ovarian cancer patient's survival: targeting Clusterin improves response to paclitaxel
por: Hassan, Mohamed K, et al.
Publicado: (2011)

Circulating Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Cardiac Amyloidosis
por: Tanaka, Komei, et al.
Publicado: (2013)

Systems proteomic analysis reveals that clusterin and tissue inhibitor of metalloproteinases 3 increase in leptomeningeal arteries affected by cerebral amyloid angiopathy
por: Manousopoulou, A., et al.
Publicado: (2016)

Therapeutic potential of matrix metalloproteinases in Duchenne muscular dystrophy
por: Ogura, Yuji, et al.
Publicado: (2014)

Therapeutic Potential of Matrix Metalloproteinase Inhibition in Breast Cancer
por: Radisky, Evette S., et al.
Publicado: (2017)

The Pharmacological TAILS of Matrix Metalloproteinases and Their Inhibitors
por: Das, Nabangshu, et al.
Publicado: (2020)

Matrix Metalloproteinase 9 Point-of-Care Immunoassay Result Predicts Response to Topical Cyclosporine Treatment in Dry Eye Disease
por: Park, Jae Yong, et al.
Publicado: (2018)

Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases Are Potential Biomarkers of Pulmonary and Extra-Pulmonary Tuberculosis
por: Kathamuthu, Gokul Raj, et al.
Publicado: (2020)

Interleukin-33, matrix metalloproteinase-9, and tissue ınhibitor of matrix metalloproteinase-1 in myocardial infarction
por: Guzel, Savas, et al.
Publicado: (2013)

Short-Term Therapeutic Effects of Topical Corticosteroids on Refractory Dry Eye Disease: Clinical Usefulness of Matrix Metalloproteinase 9 Testing as a Response Prediction Marker
por: Ryu, Kyung Jae, et al.
Publicado: (2021)

Matrix Metalloproteinases and Tissue Inhibitor of Metalloproteinases in Inflammation and Fibrosis of Skeletal Muscles
por: Alameddine, Hala S., et al.
Publicado: (2016)

Production of Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Human Breast Carcinomas
por: Iwata, Hiroji, et al.
Publicado: (1996)

Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Echinoderms: Structure and Possible Functions
por: Dolmatov, Igor Yu., et al.
Publicado: (2021)

Matrix Metalloproteinases as Potential Biomarkers and Therapeutic Targets in Liver Diseases
por: Geervliet, Eline, et al.
Publicado: (2020)

Dichotomous versus 5-scale grading system for the interpretation of the point-of-care immunoassay for tear matrix metalloproteinase-9 in dry eye
por: Oh, Ja Young, et al.
Publicado: (2023)

Matrix Metalloproteinase 14 in the Zebrafish: An Eye on Retinal and Retinotectal Development
por: Janssens, Els, et al.
Publicado: (2013)

Cinnamic acid derivatives as potential matrix metalloproteinase-9 inhibitors: molecular docking and dynamics simulations
por: Malekipour, Mohammad Hossein, et al.
Publicado: (2023)

Polymerizable Matrix Metalloproteinases’ Inhibitors with Potential Application for Dental Restorations
por: Laronha, Helena, et al.
Publicado: (2021)

Erratum: Interleukin-33, matrix metalloproteinase-9, and tissue inhibitor of matrix metalloproteinase-1 in myocardial infarction
por: Guzel, Savas, et al.
Publicado: (2013)

Matrix Metalloproteinase-9 and Tissue Inhibitor of Matrix Metalloproteinase-1 in Sepsis after Major Abdominal Surgery
por: Bojic, Suzana, et al.
Publicado: (2018)

Study of matrix metalloproteinases and their inhibitors in breast cancer
por: Vizoso, F J, et al.
Publicado: (2007)

Matrix metalloproteinases and their inhibitors in canine mammary tumors
por: Aresu, Luca, et al.
Publicado: (2011)

Matrix metalloproteinases and their inhibitors as biomarkers of severity in sepsis
por: Lorente, Leonardo, et al.
Publicado: (2010)

Study of matrix metalloproteinases and their inhibitors in prostate cancer
por: Escaff, S, et al.
Publicado: (2010)

The Behavior of Matrix Metalloproteinases and Their Inhibitors in Colorectal Cancer
por: Herszényi, László, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_f2cut02eq0fpm7ah1epne439t4